Literature DB >> 3432181

Amantadine in neuroleptic malignant syndrome.

A Jee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3432181      PMCID: PMC2428301          DOI: 10.1136/pgmj.63.740.508

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  8 in total

1.  Neuroleptic malignant syndrome successfully treated with amantidine.

Authors:  J Woo; R Teoh; J Vallance-Owen
Journal:  Postgrad Med J       Date:  1986-08       Impact factor: 2.401

2.  Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy.

Authors:  P Hamburg; J B Weilburg; N H Cassem; L Cohen; S Brown
Journal:  Compr Psychiatry       Date:  1986 Jul-Aug       Impact factor: 3.735

Review 3.  Current concepts. Neuroleptic malignant syndrome.

Authors:  B H Guzé; L R Baxter
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

4.  [Amantadine in malignant neuroleptic syndrome].

Authors:  M Rojtman; E Apter; S Lahav; S Tiano
Journal:  Harefuah       Date:  1981-04-01

Review 5.  Neuroleptic malignant syndrome.

Authors:  J L Levenson
Journal:  Am J Psychiatry       Date:  1985-10       Impact factor: 18.112

6.  Amantadine in the neuroleptic malignant syndrome.

Authors:  B N Gangadhar; N G Desai; S M Channabasavanna
Journal:  J Clin Psychiatry       Date:  1984-12       Impact factor: 4.384

7.  A case of neuroleptic malignant syndrome successfully treated with amantadine.

Authors:  M M McCarron; M L Boettger; J J Peck
Journal:  J Clin Psychiatry       Date:  1982-09       Impact factor: 4.384

Review 8.  The neuroleptic malignant syndrome: agent and host interaction.

Authors:  A Shalev; H Munitz
Journal:  Acta Psychiatr Scand       Date:  1986-04       Impact factor: 6.392

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.